Another GLP-1 agonist, exenatide, has initiated cellular stem proliferation through ciliary neurotrophic factor (CNTF), increased Ki-67 gene expression, and also induced microglial activation with reduction of astrogliosis [51], suggesting GLP-1 agonists utility in both AD and PD. The gene discussed is GLP1R; the disease is Alzheimer disease.